Published in Int J Psychophysiol on October 25, 2005
p38 MAP kinase inhibitor reverses stress-induced myocardial dysfunction in vivo. J Appl Physiol (1985) (2009) 0.78
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol (2005) 5.33
Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med (2008) 4.71
Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med (2007) 4.49
Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med (2004) 3.94
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol (2012) 3.66
Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med (2010) 3.57
Clinical applications of PET in oncology. Radiology (2004) 3.44
Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry (2005) 3.41
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J (2007) 3.34
Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol (2012) 3.19
Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med (2006) 3.15
Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol (2008) 2.96
Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol (2003) 2.87
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83
Polygenic risk, rapid childhood growth, and the development of obesity: evidence from a 4-decade longitudinal study. Arch Pediatr Adolesc Med (2012) 2.70
Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med (2010) 2.58
Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol (2007) 2.57
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation (2014) 2.50
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol (2002) 2.50
Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med (2009) 2.34
Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med (2007) 2.33
Central nervous system injury associated with cardiac surgery. Lancet (2006) 2.27
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology (2012) 2.26
Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler Thromb Vasc Biol (2007) 2.08
A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thorac Cardiovasc Surg (2003) 2.07
Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension (2010) 2.07
Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery. Stroke (2013) 2.05
Exercise and the treatment of clinical depression in adults: recent findings and future directions. Sports Med (2002) 2.02
Nighttime blood pressure dipping in postmenopausal women with coronary heart disease. Am J Hypertens (2012) 2.02
A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med (2008) 1.95
Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men. Am J Cardiol (2002) 1.92
Social support and coronary heart disease: epidemiologic evidence and implications for treatment. Psychosom Med (2005) 1.88
Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology (2003) 1.87
Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. Psychosom Med (2006) 1.87
Mammotomography with pinhole incomplete circular orbit SPECT. J Nucl Med (2003) 1.78
Emotional antecedents of hot flashes during daily life. Psychosom Med (2005) 1.77
Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology (2012) 1.74
Effects of perceived racism and anger inhibition on ambulatory blood pressure in African Americans. Psychosom Med (2003) 1.72
Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. J Am Coll Cardiol (2011) 1.71
Ethnic differences in the treatment of depression in patients with ischemic heart disease. Am Heart J (2008) 1.70
Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med (2005) 1.70
Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry. J Nucl Med (2014) 1.68
Effects of a telephone-based psychosocial intervention for patients awaiting lung transplantation. Chest (2002) 1.66
History of depression and survival after acute myocardial infarction. Psychosom Med (2009) 1.65
Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med (2004) 1.64
Effects of spouse-assisted coping skills training and exercise training in patients with osteoarthritic knee pain: a randomized controlled study. Pain (2004) 1.63
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol (2003) 1.62
Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry. J Nucl Med (2008) 1.62
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors. Neuro Oncol (2008) 1.59
Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci U S A (2011) 1.59
Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6. J Nucl Med (2007) 1.57
Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hypertens (2002) 1.56
Nighttime blood pressure dipping in young adults and coronary artery calcium 10-15 years later: the coronary artery risk development in young adults study. Hypertension (2012) 1.56
Hostility, social support, and adrenergic receptor responsiveness among African-American and white men and women. Psychosom Med (2003) 1.55
Effects of coping skills training and sertraline in patients with non-cardiac chest pain: a randomized controlled study. Pain (2011) 1.55
First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer. J Nucl Med (2013) 1.51
Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med (2006) 1.51
Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study. Nephrol Dial Transplant (2011) 1.50
Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience. Radiology (2005) 1.49
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol Aging (2012) 1.49
Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET Registry. Mol Imaging Biol (2011) 1.49
Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol (2002) 1.48
Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts. J Nucl Med (2012) 1.47
Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol (2005) 1.47
Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group. J Clin Oncol (2004) 1.45
Evaluation and management of the patient with difficult-to-control or resistant hypertension. Am Fam Physician (2009) 1.41
Serum creatinine patterns in coronary bypass surgery patients with and without postoperative cognitive dysfunction. Anesth Analg (2002) 1.41
Sex differences in the endothelial function of untreated hypertension. J Clin Hypertens (Greenwich) (2012) 1.39
Pain catastrophizing and pain-related fear in osteoarthritis patients: relationships to pain and disability. J Pain Symptom Manage (2008) 1.39
Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. Neuro Oncol (2007) 1.39
Cost-effectiveness of electrocardiography vs. electrocardiography plus limited echocardiography to diagnose LVH in young, newly identified, hypertensives. Am J Hypertens (2010) 1.39